Instem plc

About Instem plc

Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Logbook, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities in non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; SEND Explorer, a web-based application with optional data warehousing capabilities; SENDTrial, a web based solution that can be accessed through a subscription; and standard for exchange of nonclinical data solutions. Further, the company provides Sorcerer Colony Counter for automatic plate counter; sales support, training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; and software solutions to extract intelligence from research and development related healthcare data. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.

https://www.instem.com

INS.L United Kingdom

630USD30 (-4.76%)

• At close Thu Jun 01 2023

LSE exchange

Sector: Healthcare

Industry: Health Information Services

Location United Kingdom, Stone

Grade: ADC

193,124,882 USD
MARKET CAP
3050.000
PE
.
BETA (5y)
0.200
EPS

Profits

for 5 years
260%
for 3 years
37%
for 2 years
25%
for last year
-15%
for this year
-11%
Instem plc
© 2025 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.